0 Comment
Pablo G. Hermida | Santander (EFE).- Headaches, a practically “universal” problem, have a “big culprit”, the CGRP molecule, which could be the biomarker neurology needs to confirm diagnoses, monitor patients and find out the efficacy of the treatments. In an interview with EFE, neurologists from the Cantabrian hospital in Valdecilla, Julio Pascual and Vicente González-Quintanilla,... Read More